The estimated Net Worth of Margaret Liu is at least $3.78 Thousand dollars as of 20 May 2024. Margaret Liu owns over 4,500 units of Sangamo Therapeutics Inc stock worth over $3,780 and over the last 20 years Margaret sold SGMO stock worth over $0.
Margaret has made over 1 trades of the Sangamo Therapeutics Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently Margaret exercised 4,500 units of SGMO stock worth $3,780 on 20 May 2024.
The largest trade Margaret's ever made was exercising 4,500 units of Sangamo Therapeutics Inc stock on 20 May 2024 worth over $3,780. On average, Margaret trades about 563 units every 0 days since 2005. As of 20 May 2024 Margaret still owns at least 4,500 units of Sangamo Therapeutics Inc stock.
You can see the complete history of Margaret Liu stock trades at the bottom of the page.
Margaret's mailing address filed with the SEC is 9704 MEDICAL CENTER DRIVE, , ROCKVILLE, MD, 20850.
Over the last 24 years, insiders at Sangamo Therapeutics Inc have traded over $87,969,621 worth of Sangamo Therapeutics Inc stock and bought 3,434,008 units worth $48,483,268 . The most active insiders traders include Capital Management, L.P.Ra ..., Le Roy C Kopp, and Inc.Biogen Ma Inc. Biogen. On average, Sangamo Therapeutics Inc executives and independent directors trade stock every 21 days with the average trade being worth of $40,671. The most recent stock trade was executed by Inc.Biogen Ma Inc. Biogen on 26 September 2023, trading 6,000,000 units of SGMO stock currently worth $3,000,000.
for sangamo therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. to learn more about sangamo, visit the our website at www.sangamo.com.
Sangamo Therapeutics Inc executives and other stock owners filed with the SEC include: